S&P 500 5,248.49 ▲ +0.42%
NASDAQ 16,402.18 ▲ +0.66%
DOW 39,127.84 ▼ −0.11%
US 10Y 4.21% ▼ −2bp
BTC $67,420 ▲ +1.28%
GOLD $2,341 ▲ +0.18%
USD/EUR 1.0824 ▼ −0.06%
VIX 13.42 ▼ −2.4%
OIL $82.16 ▲ +1.04%
DXY 104.21 ▲ +0.08%
S&P 500 5,248.49 ▲ +0.42%
NASDAQ 16,402.18 ▲ +0.66%
DOW 39,127.84 ▼ −0.11%
US 10Y 4.21% ▼ −2bp
BTC $67,420 ▲ +1.28%
GOLD $2,341 ▲ +0.18%
USD/EUR 1.0824 ▼ −0.06%
VIX 13.42 ▼ −2.4%
OIL $82.16 ▲ +1.04%
DXY 104.21 ▲ +0.08%
Latest› Regulation› Story
Regulation · May 13, 2026

UBS Ordered to Pay $1.2M in FINRA Arbitration Over Variable Annuity and Margin Loan Claims

A FINRA panel found UBS liable for $1.18 million in damages and $36,000 in costs to a client who alleged misconduct tied to retirement funds and margin borrowing.

UBS Ordered to Pay $1.2M in FINRA Arbitration Over Variable Annuity and Margin Loan Claims Photo · James O'Connell for InvestLin

UBS Financial Services Inc. suffered a $1.2 million arbitration loss last week, as a three-person FINRA panel found the firm liable for damages tied to its handling of variable annuities and margin loans. The award, issued Thursday under FINRA Dispute Resolution Services, included $1.18 million in compensatory damages and $36,000 in costs.

The claimant, Kelly Goldsmith, filed the complaint in 2023 alleging breach of fiduciary duty, negligence, and other claims. According to the arbitration award, the dispute centered on the purchase of a variable annuity with retirement funds and the use of margin in her account. Goldsmith had originally sought $2 million in compensatory damages.

UBS declined to comment on the award. Bruce Oakes, Goldsmith's attorney, did not respond to requests for comment. The case highlights ongoing risks for advisors and firms when recommending complex products like variable annuities, especially when combined with margin borrowing.

Industry experts note that variable annuity sales have grown in the rising interest rate environment, raising concerns about unsuitable switching. Advisors may generate fresh commissions by rewriting annuity contracts, often incurring surrender charges and fees for clients. However, this case does not appear to involve switching; rather, it involves a client borrowing on margin, a common but risky practice.

By the numbers
$1.2M
total arbitration award against UBS
$1.18M
compensatory damages awarded
$36,000
costs awarded
$92M
February 2025 arbitration award against UBS

UBS has a track record of costly litigation from volatile investment products, including its YES options strategy, Puerto Rico bonds and bond funds, and Lehman Brothers structured notes. This winter, the firm lost a $5.5 million lawsuit to Kyle Blackmon, a real estate broker with Compass Inc., over handling of shares and options around Compass's 2021 IPO. Blackmon had sought $19.7 million.

At the end of last month, UBS was denied its motion to vacate a $92 million arbitration award from February 2025. That case involved nine investors who alleged UBS engaged in a high-risk trading strategy linked to a financial advisor shorting Tesla Inc. (TSLA) shares. The firm had deemed the award unfair but failed to overturn it.

For advisors, these cases underscore the importance of suitability and disclosure when recommending variable annuities and margin strategies. As retirement timing analysis becomes more critical, ensuring that products align with client goals is paramount. Additionally, the growing demand for integrated wealth advice, as noted in a recent study on average inheritances nearing $1 million, may increase scrutiny on advisor recommendations.

The FINRA arbitration system continues to be a key forum for investor claims, and firms face significant financial exposure when compliance lapses occur. UBS's recent losses, totaling over $98 million in just a few months, signal that regulators and arbitrators are holding firms accountable for misconduct.

JO
About the author

James O'Connell

Regulation & Compliance Editor · Washington, D.C.

Covers the SEC, FINRA, DOL and state regulators from Washington, D.C.

Next story · Don't miss

Inspired Healthcare asset sale yields $713M, 59% of $1.2B raised from investors

Bankruptcy court approves sale of 30 properties, but investor recoveries remain uncertain amid fee disputes and arbitration hurdles.

Read the story →
Inspired Healthcare asset sale yields $713M, 59% of $1.2B raised from investors